Does SELUMETINIB Cause Pulmonary embolism? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Pulmonary embolism have been filed in association with SELUMETINIB (KOSELUGO). This represents 0.6% of all adverse event reports for SELUMETINIB.
7
Reports of Pulmonary embolism with SELUMETINIB
0.6%
of all SELUMETINIB reports
2
Deaths
5
Hospitalizations
How Dangerous Is Pulmonary embolism From SELUMETINIB?
Of the 7 reports, 2 (28.6%) resulted in death, 5 (71.4%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SELUMETINIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does SELUMETINIB Cause?
Blood creatine phosphokinase increased (105)
Rash (89)
Off label use (78)
Paronychia (73)
Dermatitis acneiform (61)
Diarrhoea (59)
Fatigue (54)
Acne (52)
Nausea (49)
Death (47)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which SELUMETINIB Alternatives Have Lower Pulmonary embolism Risk?
SELUMETINIB vs SEMAGLUTIDE
SELUMETINIB vs SEMUSTINE
SELUMETINIB vs SENNA LEAF
SELUMETINIB vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B
SELUMETINIB vs SENNOSIDES